StockData
CapsoVision, Inc logo

CapsoVision, Inc (CV) stock

CVNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30733% above fair value
$6.82+0.17 (+2.56%)

Close on Nov 18, 2026Market cap $341.32MP/E –Yield –

CapsoVision revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

CapsoVision's revenue for the twelve months ending Jun 30, 2026 was $13.89M, up 11.0% year over year. For fiscal 2025 it was $13.55M, up 15.3% from the year before.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$13.55M+15.3%
FY2024Dec 31, 2024$11.76M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$3.64M+9.9%
Q1 FY2026Mar 31, 2026$2.79M+0.3%
Q4 FY2025Dec 31, 2025$3.92M+13.5%
Q3 FY2025Sep 30, 2025$3.54M+19.3%
Q2 FY2025Jun 30, 2025$3.32M+16.6%
Q1 FY2025Mar 31, 2025$2.78M–
Q4 FY2024Dec 31, 2024$3.45M–
Q3 FY2024Sep 30, 2024$2.97M–
Q2 FY2024Jun 30, 2024$2.84M–

More CapsoVision figures

See a number that looks wrong?